These effects, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the idea of targeting ACKR3 as a singular strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar disorders.A fresh review displays the compound conolidin… Read More